Insulin resistance and implications for hippocampal volume/function and the default mode network

Figure 15.1

Scatterplot between HOMA-IR and right hippocampal volume corrected for total brain volume (Rasgon et al., 2011).



Results also indicated significant associations between higher HOMA-IR and reduced scores on a global measure of cognition (MMSE), estimated IQ, and verbal and visual attention measures regardless of APOE ε-4 carrier status. Figure 15.2 displays a scatterplot between HOMA-IR and MMSE.



Figure 15.2

Scatterplot between HOMA-IR and MMSE (Rasgon et al., 2011).


Given that the study sample included postmenopausal women currently using hormone therapy, subsequent analyses assessed the possible confounding effects of the reproductive variables of endogenous and exogenous estrogen exposure. The relationship between HOMA-IR on right and total hippocampal volume, as well as MMSE scores, remained significant whereas reproductive variables on either hippocampal volumes or cognitive variables did not.




Insulin resistance and the default mode network


Pioneering work by a number of investigators has established the importance of the default mode network (DMN), or “resting state” network, as a biomarker of cognitive function and age-related decline (Greicius, Srivastava, Reiss, & Menon, 2004; Sorg et al., 2007; Zhou et al., 2010). Indeed, the DMN has proven to be a robust correlate of pathological brain aging (Zhou et al., 2010) and risk of dementia (Luchsinger, 2010). It encompasses widely separate brain regions, including the medial prefrontal cortex (MPFC), the posterior cingulate cortex (PCC), and lateral parietal cortices, all of which display a high degree of functional activity during rest (Fox et al., 2005). The DMN essentially “deactivates” during mental tasks with moderate or greater cognitive demand and “activates” during mental rest with eyes closed (Fox et al., 2005). Utilizing functional connectivity analysis allows the opportunity to examine DMN connections with critical brain regions, such as the hippocampus. Previous data on DMN functional connectivity in patients with DM2 are limited to one report (Musen et al., 2012), which identified that HOMA-IR was inversely correlated with reduced functional connectivity within the DMN, compared with control subjects.


Insulin resistance in risk for pathological brain aging was also assessed by utilizing a contrast analysis of functional connectivity between the DMN and the hippocampus during rest using fMRI in a subsample (n = 20) of women from the above study (Kenna et al., 2013). The sample was dichotomized into two groups based on the overall group mean fasting plasma insulin value (e.g. higher insulin levels (> 8 μIU/mL) and lower insulin levels ( 8 μIU/mL)).


Initial functional connectivity analysis showed the expected positive associations among the main DMN nodes (i.e. the MPFC, PCC, bilateral LPC), as well as reciprocal associations between the left and right hippocampal regions in the total sample (Figure 15.3). In the dichotomized groups, those with higher insulin exhibited significantly reduced positive associations between the MPFC seed and left and right parahippocampal regions, and conversely, between both the left and right hippocampal seed regions and the MPFC region, relative to subjects with lower insulin levels (Figure 15.4). Functional connectivity between the PCC and LPC with the hippocampal regions did not differ between the two contrast groups.



Figure 15.3

Functional connectivity maps for the higher insulin and lower insulin contrast groups. (A) Brain regions that showed positive association with seed regions’ time series. Seeds were placed in the DMN regions as well as in the left and right hippocampi. Weighted average of the four seed regions for the DMN and two seed regions for the hippocampi are shown in this figure (p = 0.01 whole-brain corrected). Maps of each individual seed region are shown. Red circles indicate brain regions that displayed activation in the lower insulin group (red) but not the higher insulin group (blue), and are in the MPFC and hippocampal regions. (B) Between-group differences in functional connectivity. Upper panel: Seed regions where the functional connectivity maps showed significant differences between groups. Lower panel: Compared with the lower insulin group, higher insulin subjects showed significantly reduced positive associations between the MPFC seed and bilateral hippocampal regions (pink-purple) as well as reduced positive associations between the left hippocampal seed and MPFC region (orange-yellow) and right hippocampal seed and MPFC (blue-green) (p = 0.01 whole-brain corrected) (Kenna et al., 2013).



Figure 15.4

Functional connectivity maps for the higher insulin and lower insulin groups. Brain regions that displayed positive associations with seed regions’ time series. Seeds were placed in the DMN, MPFC, PCC, left and right LPC, and left and right hippocampi; p = –0.01 corrected (Kenna et al., 2013).


Exploration of potential confounding effects of group differences in IQ and executive function on the significant brain regions showed continued significant main effects of insulin group on MPFC–hippocampal connectivity even when controlling for IQ. Correlations of the MPFC–hippocampal connectivity and fasting plasma insulin values in the group as a whole were observed to be much stronger in the right and left hippocampus than connectivity with IQ.


These two described studies are the first, to our knowledge, to report on the effects of the modifiable risk factor, IR, on structural and functional integrity of the hippocampus. These findings may have a direct impact on patients with MDD who are at heightened risk for both IR and pathological brain aging. While we can only speculate, pending further data, we suggest that IR acts as a catalyst for deleterious brain morphology and network connectivity.



Summary


There is strong converging evidence to support the negative effects of glucose dysregulation on brain structure and function that lead to cognitive decline and dementia. Our cumulative findings suggest that in middle-aged, euthymic adults with a history of MDD, indirect measures of IR are associated with disrupted memory and executive functioning, and corresponding metabolic decline in the MPFC, reductions in hippocampal volumes, and aberrant intrinsic connectivity between the hippocampus and MPFC (Kenna et al., 2013; Rasgon et al., 2011, 2014). Insulin resistance is the underlying metabolic condition of DM2, and may be corrected with pharmacological and behavioral treatments. Together with the literature to date on the impact of IR on cognitive function and risk of MDD, the cumulative data strongly suggest the importance of clinically addressing IR in aging individuals, especially those with a history of MDD. Taken together, the evidence underscores the importance of identifying IR in patients with MDD and the development of interventions to prevent the onset of DM2.





References


Abbatecola, A. M., Paolisso, G., Lamponi, M., Bandinelli, S., Lauretani, F., Launer, L., & Ferrucci, L. (2004). Insulin resistance and executive dysfunction in older persons. Journal of the American Geriatrics Society, 52(10): 17131718.

Adriaanse, M. C., Dekker, J. M., Nijpels, G., Heine, R. J., Snoek, F. J., & Pouwer, F. (2006). Associations between depressive symptoms and insulin resistance: The Hoorn Study. Diabetologia, 49(12): 28742877.

Akomolafe, A., Beiser, A., Meigs, J. B., Au, R., Green, R. C., Farrer, L. A., … Seshadri, S. (2006). Diabetes mellitus and risk of developing Alzheimer disease: Results from the Framingham Study. Archives of Neurology, 63(11): 15511555.

Anttila, S. & Leinonen, E. (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Reviews, 7(3): 239264.

Arroyo, C., Hu, F., Ryan, L., Kawachi, I., Colditz, G., Speizer, F., & Manson, J. (2004). Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care, 27(1): 129133.

Awad, N., Gagnon, M., Desrochers, A., Tsiakas, M., & Messier, C. (2002). Impact of peripheral glucoregulation on memory. Behavioral Neuroscience, 116(4): 691702.

Awad, N., Gagnon, M., & Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26(8): 10441080.

Banki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992). CSF corticotropin-releasing hormone and somatostatin in major depression: Response to antidepressant treatment and relapse. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 2(2): 107113.

Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H., Born, J., & Kern, W. (2004). Intranasal insulin improves memory in humans. Psychoneuroendocrinology, 29(10): 13261334.

Benkert, O., Szegedi, A., & Kohnen, R. (2000). Mirtazapine compared with paroxetine in major depression. Journal of Clinical Psychiatry, 61(9): 656663.

Bot, M., Pouwer, F., De Jonge, P., Nolan, J. J., Mari, A., Hojlund, K., … Dekker, J. M. (2013). Depressive symptoms, insulin sensitivity and insulin secretion in the RISC cohort study. Diabetes & Metabolism, 39(1): 4249.

Boyer, W. & Feighner, J. (1992). An overview of paroxetine. Journal of Clinical Psychiatry, 53(Suppl.): 36.

Brown, L., Majumdar, S., Newman, S., & Johnson, J. (2005). History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care, 28(5): 10631067.

Bruehl, H., Sweat, V., Hassenstab, J., Polyakov, V., & Convit, A. (2010). Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. Journal of Clinical and Experimental Neuropsychology, 32(5): 487493.

Carnethon, M., Kinder, L., Fair, J., Stafford, R., & Fortmann, S. (2003). Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992. American Journal of Epidemiology, 158(5): 416423.

Casper, R., Davis, J., Pandey, G., Garver, D., & Dekirmenjian, H. (1977). Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology, 2(2): 105113.

Centers for Disease Control and Prevention (2011). National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

Cheng, B. & Mattson, M. (1992). IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. Journal of Neuroscience, 12(4): 15581566.

Chiba, M., Suzuki, S., Hinokio, Y., Hirai, M., Satoh, Y., Tashiro, A., … Toyota, T. (2000). Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism, 49(9): 11451149.

Clarke, D., Boyd, F., Kappy, M., & Raizada, M. (1984). Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. Journal of Biological Chemistry, 259: 1167211675.

Convit, A., Wolf, O. T., Tarshish, C., & de Leon, M. J. (2003). Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proceedings of the National Academy of Sciences of the United States of America, 100(4): 20192022.

Craft, S. (2005). Insulin resistance syndrome and Alzheimer’s disease: Age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiology of Aging, 26(Suppl. 1): 6569.

Craft, S.S. (2006). Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications. Alzheimer Disease and Associated Disorders, 20(4): 298301.

Craft, S.S. (2009). The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Archives of Neurology, 66(3): 300305.

Craft, S., Asthana, S., Cook, D., Baker, L., Cherrier, M., Purganan, K., … Krohn, A. J. (2003). Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: Interactions with apolipoprotein E genotype. Psychoneuroendocrinology, 28(6): 809822.

Craft, S., Asthana, S., Schellenberg, G., Baker, L., Cherrier, M., Boyt, A., … Plymate, S. (2000). Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer’s disease differ according to apolipoprotein-E genotype. Annals of the New York Academy of Sciences, 903: 222228.

Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L., Newcomer, J., … Grimwood, K. (1999). Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology, 70(2): 146152.

Craft, S. & Watson, G. (2004). Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurology, 3(3): 169178.

Curb, J. D., Rodriguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K. H., … White, L. R. (1999). Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance. Neurology, 52(5): 971975.

Davis, S., Colburn, C., Dobbins, R., Nadeau, S., Neal, D., & Williams, P. (1995). Evidence that the brain of the conscious dog is insulin sensitive. Journal of Clinical Investigation, 95(2): 593602.

de Leon, M., Desanti, S., Zinkowski, R., Mehta, P., Pratico, D., Segal, S., … Rusinek, H. (2004). MRI and CSF studies in the early diagnosis of Alzheimer’s disease. Journal of Internal Medicine, 256(3): 205223.

Delaunay, F., Khan, A., Cintra, A., Davani, B., Ling, Z. C., Andersson, A., … Okret, S. (1997). Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. Journal of Clinical Investigation, 100(8): 20942098.

den Heijer, T., Vermeer, S., van Dijk, E., Prins, N., Koudstaal, P., Hofman, A., & Breteler, M. M. (2003). Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia, 46(12): 16041610.

Dringen, R. & Hamphrecht, B. (1992). Glucose, insulin, and insulin-like growth factor I regulate the glycogen content of atroglia-rich primary cultures. Journal of Neurochemistry, 58(2): 511517.

Dunaif, A., Segal, K., Futterweit, W., & Dobrjansky, A. (1989). Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38(9): 11651174.

Eaton, W., Armenian, H., Gallo, J., Pratt, L., & Ford, D. (1996). Depression and risk for onset of type II diabetes: A prospective population-based study. Diabetes Care 19(10): 10971102.

Enzinger, C., Fazekas, F., Matthews, P., Ropele, S., Schmidt, H., Smith, S., … Schmidt, R. (2005). Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology, 64(10): 17041711.

Everson-Rose, S., Meyer, P., Powell, L., Pandey, D., Torrens, J., Kravitz, H., … Matthews, K. A. (2004). Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care, 27(12): 28562862.

Facchini, F., Hua, N., Abbasi, F., & Reaven, G. (2001). Insulin resistance as a predictor of age-related diseases. Journal of Clinical Endocrinology & Metabolism, 86(8): 35743578.

Farin, H., Abbasi, F., & Reaven, G. (2005). Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism, 54(10): 13231328.

Farin, H., Abbasi, F., & Reaven, G. (2006). Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. American Journal of Clinical Nutrition, 83(1): 4751.

Fava, M. (2000). Weight gain and antidepressants. Journal of Clinical Psychiatry, 61(Suppl. 11): 3741.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 18, 2017 | Posted by in PSYCHIATRY | Comments Off on Insulin resistance and implications for hippocampal volume/function and the default mode network

Full access? Get Clinical Tree

Get Clinical Tree app for offline access